Editas Medicine, Inc. (EDIT)
2.17
+0.03
(+1.40%)
USD |
NASDAQ |
Nov 13, 16:00
2.165
0.00 (0.00%)
After-Hours: 19:59
Editas Medicine Market Cap : 333.44M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 333.44M |
| November 12, 2026 | 328.83M |
| November 11, 2026 | 365.71M |
| November 10, 2026 | 384.91M |
| November 09, 2026 | 422.56M |
| November 06, 2026 | 394.90M |
| November 05, 2026 | 391.83M |
| November 04, 2026 | 417.60M |
| November 03, 2026 | 399.18M |
| November 02, 2026 | 394.57M |
| October 30, 2026 | 409.93M |
| October 29, 2026 | 449.85M |
| October 28, 2026 | 452.92M |
| October 27, 2026 | 399.18M |
| October 26, 2026 | 368.47M |
| October 23, 2026 | 368.47M |
| October 22, 2026 | 382.29M |
| October 21, 2026 | 385.36M |
| October 20, 2026 | 396.11M |
| October 19, 2026 | 371.54M |
| October 16, 2026 | 360.80M |
| October 15, 2026 | 374.62M |
| October 14, 2026 | 348.52M |
| October 13, 2026 | 375.38M |
| October 12, 2026 | 422.21M |
| Date | Value |
|---|---|
| October 09, 2026 | 445.24M |
| October 08, 2026 | 436.03M |
| October 07, 2026 | 422.21M |
| October 06, 2026 | 419.14M |
| October 05, 2026 | 428.35M |
| October 02, 2026 | 402.25M |
| October 01, 2026 | 386.90M |
| September 30, 2026 | 394.57M |
| September 29, 2026 | 397.64M |
| September 28, 2026 | 385.36M |
| September 25, 2026 | 396.11M |
| September 24, 2026 | 422.21M |
| September 23, 2026 | 413.00M |
| September 22, 2026 | 448.31M |
| September 21, 2026 | 434.49M |
| September 18, 2026 | 414.53M |
| September 17, 2026 | 417.60M |
| September 16, 2026 | 416.07M |
| September 15, 2026 | 403.79M |
| September 14, 2026 | 420.67M |
| September 11, 2026 | 414.53M |
| September 10, 2026 | 406.86M |
| September 09, 2026 | 425.28M |
| September 08, 2026 | 465.20M |
| September 04, 2026 | 495.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Vertex Pharmaceuticals, Inc. | 136.55B |
| Recursion Pharmaceuticals, Inc. | 1.787B |
| Halozyme Therapeutics, Inc. | 11.42B |
| Novavax, Inc. | 1.407B |
Market Cap Related Metrics
| PS Ratio | 5.096 |
| Price to Book Value | 3.945 |
| Price | 2.17 |
| Earnings Yield | -28.48% |